Replies to post #521592 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

That is a current trial, not the one that led to their approval. Note you did not give the Link. Those are the facts. Don’t deceive.

Those were not the primary endpoints for the trial that led to approval and the trial you took that from only started in July 2020.

It’s a combination trial with temozolomide.

https://clinicaltrials.gov/ct2/show/NCT04471844

Lies are no way to win an argument. It did not get approved based on OS but on PFS and a hypothetical OS, projected out 5 years. The current trial you referred to has not even run 5 years yet. I will be interested to see how that one turns out, but your post misleads in response to mine.